Demonstration of hepatitis C virus genome in saliva and urine of patients with type C hepatitis
Numata, N.; Kanno, A.; Ohori, H.
Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 477-482
1995
ISSN/ISBN: 0047-1852 PMID: 7563797 Document Number: 451969
Document emailed within 1 workday
Related Documents
Son, H.-C.; Yoon, M.-S.; Kim, Y.-J.; Kim, I.-H.; Kim, Y.-S. 2002: Type-specific antibody for hepatitis C virus detected by use of NS-4 peptide and hepatitis C virus genome in Korea Rinsho Byori. Japanese Journal of Clinical Pathology 50(5): 533-540Villari, D.; Pernice, M.; Spinella, S.; Squadrito, G.; Rodinò, G.; Brancatelli, S.; Longo, G.; Raimondo, G. 1995: Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study American Journal of Gastroenterology 90(6): 955-958
Pastore, L.; Fiore, J.R.; Tateo, M.; De Benedittis, M.; Petruzzi, M.; Casalino, C.; Genchi, C.; Lo Muzio, L.; Angarano, G.; Serpico, R. 2006: Detection of hepatitis C virus-RNA in saliva from chronically HCV-infected patients International Journal of Immunopathology and Pharmacology 19(1): 217-224
Zhang, X.; Xiong, S.; Lu, Z. 1997: Quantitative detection of serum hepatitis B wild type virus and the precore mutant genomes using competitive polymerase chain reaction in patients with HBeAg(-) chronic hepatitis B Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 11(1): 33-36
Fried, M.W.; Shindo, M.; Fong, T.L.; Fox, P.C.; Hoofnagle, J.H.; Di Bisceglie, A.M. 1992: Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C Gastroenterology 102(4 Part 1): 1306-1308
El-Sayed, N.M.; el-Halawani, T.A. 1995: Comparative study of serum and salivary hepatitis B surface antigen and hepatitis C antibodies among patients infected with hepatitis B or C virus Egyptian Dental Journal 41(3): 1305-1312
Sungkanuparph, S.; Vibhagool, A.; Manosuthi, W.; Kiertiburanakul, S.; Atamasirikul, K.; Aumkhyan, A.; Thakkinstian, A. 2004: Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study Journal of the Medical Association of Thailand 87(11): 1349-1354
Borón, P.; Sokolewicz-Bobrowska, E.; Dzikowski, M. 1974: Demonstration of hepatitis B antigen in relation to the behavior of liver indicator-enzymes patients with viral hepatitis Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 29(24): 1016-1018
Gordon, S.C.; Kodali, V.P.; Silverman, A.L.; Dmuchowski, C.F.; Urdea, M.S.; Chan, C.S.; Wilber, J.C. 1994: Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis American Journal of Gastroenterology 89(9): 1458-1461
Lai, M.Y.; Chen, D.S.; Lee, S.C.; Su, I.J.; Yang, P.M.; Hsu, H.C.; Sung, J.L. 1988: Reactivation of hepatitis B virus in anti-HBe-positive chronic active type B hepatitis: molecular and immunohistochemical studies Hepato-Gastroenterology 35(1): 17-21
Rakela, J.; Redeker, A.G.; Weliky, B. 1983: Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis Gastroenterology 84(5 Part 1): 956-960
Patorska-Mach, E.; Pieciński, Z.; Siuciak, J. 1972: Incidence of Australia antigen in patients with acute virus hepatitis and chronic hepatic disorders following virus hepatitis in our records Polski Tygodnik Lekarski 27(50): 1975-1977
Laufer, N.; Cassino, L.; Bolcic, F.; Moretti, F.; Reynoso, R.; Bouzas, M.B.; Cahn, P.; Salomón, H.; Quarleri, J. 2008: Uncommon hepatitis B virus and/or hepatitis C virus occult infection in HIV-positive patients with abnormal level of hepatic enzyme Journal of Acquired Immune Deficiency Syndromes 49(2): 233-234
Tung, H.-D.; Lu, S.-N.; Lee, C.-M.; Wang, J.-H.; Chen, T.-M.; Hung, C.-H.; Huang, W.-S.; Changchien, C.-S. 2002: Antiviral treatment responses in patients with chronic hepatitis C virus infection evaluated by a third generation anti-hepatitis C virus assay Journal of Viral Hepatitis 9(4): 304-308
Toussirot, E.; Le Huédé, Gëlle.; Mougin, C.; Balblanc, J-Charles.; Bettinger, D.; Wendling, D. 2002: Presence of hepatitis C virus RNA in the salivary glands of patients with Sjögren's syndrome and hepatitis C virus infection Journal of Rheumatology 29(11): 2382-2385
Iroezindu, M.O.; Daniyam, C.A.; Agbaji, O.O.; Isa, E.S.; Okeke, E.N.; Imade, G.E. 2013: Prevalence of hepatitis B e antigen among human immunodeficiency virus and hepatitis B virus co-infected patients in Jos, Nigeria Journal of Infection in Developing Countries 7(12): 951-959
Saitta, C.; Pontisso, P.; Brunetto, M.R.; Fargion, S.; Gaeta, G.B.; Niro, G.A.; Picciotto, A.; Smedile, A.; Squadrito, G.; Raimondo, G. 2006: Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy Antiviral Therapy 11(7): 931-934
Saravanan, S.; Velu, V.; Nandakumar, S.; Madhavan, V.; Shanmugasundaram, U.; Murugavel, K.G.; Balakrishnan, P.; Kumarasamy, N.; Solomon, S.; Thyagarajan, S.P. 2009: Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease Journal of Microbiology Immunology and Infection 42(2): 122-128
Pivert, A.; Payan, C.; Lunel, F.; C, E.R.T. A. 2004: Comparaison des cinétiques de l'ARN et de l'antigène de capside du virus de l'hépatite C dans le suivi thérapeutique des patients co-infectés par le virus de l'hépatite C et le virus de l'immunodéficience humaine, traités par bithérapie interféron-ribavirine, dans le cadre du protocole RIBAVIC - Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol Pathologie et Biologie 52(9): 522-528
Saves, M.; Raffi, F.; Clevenbergh, P.; Marchou, B.; Waldner-Combernoux, A.; Morlat, P.; LeMoing, V.; Riviere, C.; Chene, G.; Leport, C.; The APROCOStudy Group, 2000: Hepatitis B or Hepatitis C Virus Infection Is a Risk Factor for Severe Hepatic Cytolysis after Initiation of a Protease Inhibitor-Containing Antiretroviral Regimen in Human Immunodeficiency Virus-Infected Patients Antimicrobial Agents and Chemotherapy 44(12): 3451-3455